Physician profile
Eric Shoenfeld
NPI 1902984115
$1,000.88
in general payments reported to CMS, 2019-2025
16 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $64.98 · 2021: $121 · 2022: $77.98 · 2023: $22.46 · 2024: $181 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $397.54 | 2019-2025 | Wegovy, Ozempic, Saxenda |
| Abbvie INC. | $143.11 | 2021-2025 | |
| Lilly USA, LLC | $59.35 | 2022-2023 | Mounjaro |
| Phathom Pharmaceuticals, INC. | $48.96 | 2024 | Voquezna |
| Janssen Pharmaceuticals, INC | $46.26 | 2019 | |
| Renalytix Ai, INC. | $44.50 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Amgen INC. | $44.40 | 2019-2025 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.58 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $36.35 | 2025 | Farxiga, Airsupra |
| Exact Sciences Corporation | $25.17 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $24.99 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.93 | 2025 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $22.69 | 2025 | Camzyos |
| Merck Sharp & Dohme LLC | $16.33 | 2021 | |
| Recordati_rare_diseases_inc. | $15.03 | 2025 | Isturisa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shoenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.